Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Phosphatidylcholine transfer protein inhibitor-1
Cat. No.:
OB0425LY-186
Appearance:
Solid
Purity:
98.01%
Identity:
Confirmed by LC-MS.
Size:
Add to basket
Product Overview
Description:
Phosphatidylcholine transfer protein inhibitor-1 is an inhibitor that specifically targets phosphatidylcholine transport protein (CPTP). It plays an important role in lipid metabolism and cell membrane construction.
Synonyms:
379723-99-6; N-((3-(N-(3-Chlorophenyl)sulfamoyl)-4-methylphenyl)carbamothioyl)-4-fluorobenzamide; N-[[3-[(3-Chlorophenyl)sulfamoyl]-4-methylphenyl]carbamothioyl]-4-fluorobenzamide; Phosphatidylcholine transfer protein inhibitor-1; N-[[3-[(3-Chlorophenyl)sulfamoyl]-4-methylanilino]-sulfanylidenemethyl]-4-fluorobenzamide
CAS No.:
379723-99-6
Compound CID:
3268787
Formula:
C21H17ClFN3O3S2
Formula Weight:
477.96
Specification
Target:
Others
Pathway:
Others
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
Phosphatidylcholine transfer protein inhibitor-1 can be used in the study of metabolic syndrome, atherosclerosis and other diseases to improve the disease state by regulating lipid metabolism.
